Skip to main content

Featured

FS visits biomedical firm in UK

Financial Secretary Paul Chan yesterday visited a biopharmaceutical company and the Royal College of Art, and attended a lunch hosted by the China-Britain Business Council, as part of his ongoing trip to London.   Mr Chan visited AstraZeneca and met the company’s senior management to learn about its drug research and development activities, as well as its latest expansion plans.   AstraZeneca indicated that following in-depth talks with Hong Kong’s Office for Attracting Strategic Enterprises, it plans to develop a research and development centre in Hong Kong and will engage in further discussion with relevant government departments on the matter.   The Financial Secretary then attended a roundtable luncheon held by the China-Britain Business Council, and met representatives of British enterprises that do business, or plan to do business, either in the Mainland or Hong Kong.   Mr Chan later visited the Royal College of Art, which collaborated with the Hong Kong Polytechnic Unive
Read more

HK, Guangdong measure welcomed

The Government welcomed an announcement by Guangdong on the recruitment of Hong Kong Chinese medicine practitioners (CMPs) by public healthcare institutions in the Mainland cities of the Guangdong-Hong Kong-Macao Greater Bay Area.   The Traditional Chinese Medicine Bureau of Guangdong Province today announced that Hong Kong CMPs will be recruited within 2021, on contract terms, by selected pilot sites of public Chinese medicine healthcare institutions in Guangzhou and Shenzhen.   The recruitment procedures, as well as terms and conditions of employment, will be determined by the relevant healthcare institutions. The authorities will take into account the implementation situation when considering whether the scope of the pilot sites should be expanded.   Secretary for Food & Health Prof Sophia Chan said the Hong Kong Special Administrative Region Government welcomes the measure and expressed gratitude to the relevant authorities of the central government and the province for their staunch support to the development of Chinese medicine in Hong Kong.   “The measure enables Hong Kong CMPs to further their practice within the national healthcare system, thereby promoting exchanges in Chinese medicine and providing Hong Kong CMPs, in particular the younger generation, with the opportunity to pursue development in the bay area."   Under Hong Kong’s Closer Economic Partnership Arrangement with the Mainland and relevant supplementary agreements, a series of policies has been in place to enable Hong Kong CMPs to practise Chinese medicine and establish healthcare institutions in the Mainland, Prof Chan added.   “The latest arrangement allows Hong Kong CMPs to practise in Mainland public healthcare institutions, thereby expanding their scope for development.”
http://dlvr.it/S6bH1C

Popular Posts